Xovoltib 20 Mg (Afatinib Dimaleate)

Price range: $840.00 through $2,826.00

Active Ingredient Afatinib Dimaleate
Manufacturer Boehringer Ingelheim India Pvt.Ltd
Packaging 7 tablets in 1 strip
Strength 20mg, 30mg, 40mg, 50mg
Delivery Time 6 To 15 days
SKU: Xovoltib 20mg (Afatinib Dimaleate)
  • 20 Mg
  • 30 Mg
  • 40 Mg
  • 50 Mg
  • 28 Tablets
  • 56 Tablet
  • 84 Tablet
Clear
SKU: Xovoltib 20 Mg (Afatinib Dimaleate) Categories: , , Tag:

Xovoltib 20 Mg (Afatinib Dimaleate)

Introduction

Xovoltib 20 Mg (Afatinib Dimaleate) is a prescription targeted anticancer medicine used to treat certain patients diagnosed with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Unlike conventional chemotherapy, Xovoltib 20 Mg (Afatinib Dimaleate) specifically targets abnormal proteins that promote cancer cell growth, helping slow disease progression while minimizing damage to many healthy cells.

Doctors prescribe Xovoltib 20 Mg (Afatinib Dimaleate) after confirming the presence of eligible EGFR mutations through approved diagnostic testing. Treatment is individualized based on the patient’s overall health, cancer stage, response to therapy, and tolerance.

Because this medication affects important cellular pathways, it should only be used under the supervision of a qualified oncologist.

What Is Xovoltib 20 Mg (Afatinib Dimaleate)?

Xovoltib 20 Mg (Afatinib Dimaleate) contains Afatinib Dimaleate, a second-generation irreversible EGFR tyrosine kinase inhibitor (TKI). It blocks signaling pathways responsible for the growth and spread of cancer cells carrying specific EGFR mutations.

Targeted therapy has transformed the treatment of certain lung cancers by providing personalized treatment options based on genetic testing rather than treating every patient the same way.

Unlike chemotherapy, targeted medicines focus on cancer-specific molecular abnormalities.

Uses of Xovoltib 20 Mg (Afatinib Dimaleate)

Doctors may prescribe Xovoltib 20 Mg (Afatinib Dimaleate) for:

EGFR Mutation-Positive Non-Small Cell Lung Cancer

The primary approved use is treating metastatic or advanced NSCLC in patients whose tumors contain eligible EGFR mutations.

Advanced Lung Cancer Management

It may help delay disease progression and improve progression-free survival in suitable patients.

Personalized Cancer Treatment

Genetic testing helps determine whether the patient is likely to benefit from treatment with Xovoltib 20 Mg (Afatinib Dimaleate).

Treatment decisions are always based on professional medical evaluation.

How Does Xovoltib 20 Mg (Afatinib Dimaleate) Work?

Cancer cells with EGFR mutations continuously receive signals telling them to grow and divide.

Afatinib works by:

  • Irreversibly blocking EGFR receptors
  • Inhibiting abnormal cell signaling
  • Slowing cancer cell multiplication
  • Reducing tumor progression
  • Limiting the spread of cancer cells

This targeted mechanism makes Xovoltib 20 Mg (Afatinib Dimaleate) different from traditional chemotherapy drugs.

Benefits of Xovoltib 20 Mg (Afatinib Dimaleate)

Potential benefits include:

Targeted Treatment

Acts specifically on EGFR-mutated cancer cells.

Oral Administration

The medicine is taken by mouth, eliminating the need for frequent intravenous infusions.

Personalized Therapy

Treatment is based on genetic testing rather than a one-size-fits-all approach.

Disease Control

It may help slow cancer progression in appropriately selected patients.

Improved Quality of Life

Some patients experience symptom improvement during successful treatment, although results vary.

Dosage and Administration

Always take Xovoltib 20 Mg (Afatinib Dimaleate) exactly as prescribed.

General recommendations include:

  • Swallow the tablet whole with water.
  • Take it on an empty stomach.
  • Usually taken at the same time each day.
  • Avoid crushing, splitting, or chewing the tablet unless instructed.
  • Continue treatment until your doctor recommends stopping.

Dose adjustments may be necessary depending on side effects or individual response.

Never increase or decrease your dose without medical advice.

Who Can Benefit from Xovoltib 20 Mg (Afatinib Dimaleate)?

This medicine may be appropriate for:

  • Adults diagnosed with EGFR mutation-positive NSCLC
  • Patients with advanced or metastatic disease
  • Individuals whose oncologist recommends targeted therapy
  • Patients undergoing personalized cancer treatment plans

Not every lung cancer patient is a suitable candidate, making genetic testing essential.

Possible Side Effects

Like all prescription medicines, Xovoltib 20 Mg (Afatinib Dimaleate) may cause side effects.

Common Side Effects

  • Diarrhea
  • Skin rash
  • Dry skin
  • Acne-like eruptions
  • Mouth sores
  • Nail changes
  • Loss of appetite
  • Fatigue
  • Itching

Less Common but Serious Side Effects

Seek immediate medical attention if you develop:

  • Severe diarrhea causing dehydration
  • Difficulty breathing
  • Persistent cough
  • Chest discomfort
  • Severe skin reactions
  • Eye pain or vision changes
  • Liver-related symptoms
  • Severe allergic reactions

Early reporting of side effects helps your healthcare team manage treatment safely.

Precautions Before Using Xovoltib 20 Mg (Afatinib Dimaleate)

Inform your healthcare provider if you have:

Lung Disorders

Existing lung disease may require closer monitoring.

Liver Problems

Dose adjustments may be required.

Kidney Disease

Your doctor will evaluate kidney function before and during treatment.

Eye Conditions

Report any history of eye disease or contact lens use.

Pregnancy

This medicine may harm an unborn baby.

Breastfeeding

Breastfeeding is generally not recommended during treatment and for a period after the last dose, as advised by your doctor.

Drug Interactions

Tell your healthcare provider about every medicine you use, including:

  • Prescription medicines
  • Over-the-counter medications
  • Herbal supplements
  • Vitamins
  • Nutritional supplements

Certain medications may increase or decrease the effectiveness of Xovoltib 20 Mg (Afatinib Dimaleate) or raise the risk of side effects.

Never begin or stop another medicine without professional guidance.

Missed Dose

If you forget to take your dose:

  • Take it as soon as you remember if sufficient time remains before the next scheduled dose.
  • Skip the missed dose if your next dose is due soon.
  • Do not take two doses together.

Follow your oncologist’s instructions for missed doses.

Overdose

Taking more than the prescribed amount may increase the risk of serious adverse effects.

Symptoms may include:

  • Severe diarrhea
  • Severe skin reactions
  • Excessive weakness
  • Dehydration

Seek emergency medical care immediately if an overdose is suspected.

Storage Instructions

Store Xovoltib 20 Mg (Afatinib Dimaleate):

  • At room temperature.
  • Away from moisture.
  • Protected from direct sunlight.
  • In the original packaging.
  • Out of reach of children and pets.

Discard expired medicines according to local pharmaceutical disposal guidelines.

Monitoring During Treatment

Regular monitoring helps ensure safe and effective therapy.

Your healthcare provider may recommend:

Physical Examinations

Routine follow-up appointments assess treatment response.

Blood Tests

These help monitor liver, kidney, and overall health.

Imaging Studies

CT scans or other imaging tests evaluate disease progression.

Side Effect Assessment

Prompt reporting of new symptoms supports early management.

Lifestyle Tips During Treatment

Patients receiving Xovoltib 20 Mg (Afatinib Dimaleate) should consider:

  • Staying well hydrated.
  • Eating balanced, nutritious meals.
  • Protecting skin from excessive sun exposure.
  • Using gentle skincare products if recommended.
  • Maintaining regular follow-up appointments.
  • Reporting new symptoms promptly.
  • Avoiding self-medication.
  • Following the treatment schedule carefully.

These supportive measures may help improve treatment tolerance.

Frequently Asked Questions (FAQs)

What is Xovoltib 20 Mg (Afatinib Dimaleate) used for?

It is used to treat certain patients with EGFR mutation-positive non-small cell lung cancer under the supervision of an oncologist.

Is Xovoltib 20 Mg (Afatinib Dimaleate) chemotherapy?

No. It is a targeted therapy known as an EGFR tyrosine kinase inhibitor.

Can I stop treatment once I feel better?

No. Continue treatment only as directed by your healthcare provider.

Does everyone with lung cancer qualify for this medicine?

No. Genetic testing is required to identify suitable EGFR mutations before treatment.

Can food affect this medicine?

It is generally recommended to take the tablet on an empty stomach according to your doctor’s instructions.

What should I do if I experience severe diarrhea?

Contact your healthcare provider immediately, as severe diarrhea can become serious if not treated promptly.

Are regular checkups necessary?

Yes. Routine monitoring helps assess treatment effectiveness and detect side effects early.

Conclusion

Xovoltib 20 Mg (Afatinib Dimaleate) is an advanced targeted therapy designed for patients with EGFR mutation-positive non-small cell lung cancer. By specifically blocking abnormal EGFR signaling, it helps slow cancer growth while supporting a personalized treatment approach. Because responses and side effects vary among individuals, regular monitoring, adherence to prescribed dosing, and close communication with your oncology team are essential. Never start, stop, or adjust Xovoltib 20 Mg (Afatinib Dimaleate) without professional medical guidance.

Disclaimer:-

This content is intended for educational and informational purposes only and should not replace professional medical advice, diagnosis, or treatment. Xovoltib 20 Mg (Afatinib Dimaleate) is a prescription medicine that should only be used under the supervision of a qualified healthcare professional. Always consult your oncologist or healthcare provider regarding your diagnosis, treatment options, dosage, potential side effects, and medication interactions. Never self-medicate or modify your prescribed treatment plan without medical advice.

Additional information

mg

20 Mg, 30 Mg, 40 Mg, 50 Mg

unit

28 Tablets, 56 Tablet, 84 Tablet

Be the first to review “Xovoltib 20 Mg (Afatinib Dimaleate)”

Your email address will not be published. Required fields are marked *

Reviews

There are no reviews yet.

Main Menu

Xovoltib 20 Mg (Afatinib Dimaleate) tablets for targeted lung cancer treatment

Xovoltib 20 Mg (Afatinib Dimaleate)

Price range: $840.00 through $2,826.00

Add to cart